Carvedilol monotherapy and lifestyle modification among young patients with arterial hypertension and overweight/obesity in primary healthcare settings
Aim. To evaluate the dynamics of cardiovascular risk factors (RFs) and quality of life (QoL) in young patients with Stage I-II arterial hypertension (AH) and overweight/obesity during pharmaceutical (carvedilol monotherapy) and non-pharmaceutical (School for AH Patient) intervention. Material and me...
Saved in:
Main Authors: | G. I. Nechaeva, E. N. Loginova, M. I. Shupina, Yu. V. Tereshchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2142 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
by: V. A. Nevzorova, et al.
Published: (2016-01-01) -
CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY
by: S. Y. Martsevich, et al.
Published: (2016-01-01) -
COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01) -
COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01) -
Clinical assessment of vasodilating carvedilol effects in patients with arterial hypertension and overweight/obesity: CAMELIA Study results
by: L. A. Sokolova, et al.
Published: (1970-01-01)